With an exponential growth in the area of personalized medicine and in particular immuno-oncology, Q2
Solutions shapes the market landscape with the largest global footprint for flow cytometry services
, innovative technology that provides high quality data with minimal variability, and continuous improvement efficiency initiatives to meet customers’ individual study needs.
Solutions’ customers have access to global central laboratories
, including three satellite translational science assay development laboratories, that are equipped with industry leading development expertise and value-added offerings that bring their drugs to market faster.
Our experienced assay development scientists, scientific advisors, immunologists, geneticists, pathologists, and bioinformaticists in our global central laboratories each play a key role in providing continued engagement with sponsors and providing custom solutions that fit our customers’ needs.
We employ flow cytometry technologies, including the BD FACSCanto II 8 Color instrument in our central laboratories worldwide and the BD FACSCanto 10 Color instrument in the U.S., U.K./EU, Singapore, and Beijing, China, which provide a more complete flow cytometry data set more efficiently for our customers.
Having helped develop 80% of the top 25 best-selling oncology drugs of 2015, we also implement an integrated scientific approach that drives successful immuno-oncology clinical studies. Download
our flow cytometry brochure to learn more about how we’re advancing personalized medicine and immuno-oncology programs to help customers in their clinical trial studies.
We take the necessary steps to ensure our customers’ clinical trial success along the drug development continuum. A new intensive flow cytometry training program is in place to support assays new to our facilities that include bench training on sample processing; data acquisition and troubleshooting; data interpretation and analysis; and ongoing internal proficiency testing schemes.
From custom flow cytometry panel design to review of the validation report, data, technology transfer and more, we encourage sponsor engagement throughout the process.
Learn more about our Quality Management System
that gives you confidence in the data we deliver.
We employ a unique quantitative standardization system in conjunction with automated offsets of daily variation in instruments to provide a proficient and cost-effective flow cytometry production environment for your study.
Using these resources, plus many more, we are shaping the healthcare market landscape. Our unique, customizable flow cytometry service exemplifies our dedication to transform science and data into actionable medical insights.
Learn more about our experience in anatomic and molecular pathology
and genomics-based assay development and testing
that provide customized, end-to-end solutions for our customers.